<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="336722">
  <stage>Registered</stage>
  <submitdate>28/03/2011</submitdate>
  <approvaldate>1/04/2011</approvaldate>
  <actrnumber>ACTRN12611000345987</actrnumber>
  <trial_identification>
    <studytitle>Parecoxib and paracetamol for pain relief following minor day stay gynaecological surgery (The PAINFREE Trial)</studytitle>
    <scientifictitle>Early postoperative analgesia from parecoxib, paracetamol or both among patients having minor gynaecological sugery</scientifictitle>
    <utrn>U1111-1120-3127</utrn>
    <trialacronym>The PAINFREE Trial</trialacronym>
    <secondaryid>Nil</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Postoperative analgesia after minor gynaecological surgery</healthcondition>
    <conditioncode>
      <conditioncode1>Anaesthesiology</conditioncode1>
      <conditioncode2>Pain management</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Arm 1: single dose intraoperative intravenous parecoxib 40 mg 
Arm 2: single dose intraoperative intravenous paracetamol 2 g 
Arm 3: single dose intraoperative intravenous parecoxib 40 mg and intravenous paracetamol 2 g
Arm 4: single dose intraoperative intravenous placebos

This 2 x2 factorial design allows efficient evaluation of two treatments and in this case comparison not only of parecoxib versus placebo and paracetomol versus placebo but also the interaction of these two drugs (both versus placebo) and evaluation of all patients receiving each drug eg. Arms 1 &amp; 2 vs Arm 4 and Arms 2 &amp; 3 vs Arm 4.</interventions>
    <comparator>Arm 4: Single dose itraoperative intravenous normal saline 200 ml and single dose intraoperative intravenous normal saline 2 ml</comparator>
    <control>Placebo</control>
    <interventioncode>Treatment: drugs</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>0-28 'overall benefit of analgesia score'. This is a validated, scored patient questionnaire consisting of 7 questions each with four response options. The maximum score is 28 and  a low score represents high benefit.</outcome>
      <timepoint>24 hours postoperatively</timepoint>
    </primaryOutcome>
    <primaryOutcome>
      <outcome>0-10 verbal numerical rating pain with movement score. with a minimum value of zero and a maximum value of ten</outcome>
      <timepoint>1 hour postoperatively</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Area under the curve pain score with movement</outcome>
      <timepoint>24 hours postoperatively</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Area under the curve pain score at rest</outcome>
      <timepoint>24 hours postoperatively</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Dilatation and curettage
American Society of Anesthesiologists physical status 1 or 2</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>70</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>Renal dysfunction
Hypertension
Ischaemic heart disease
Cerebrovascular disease
Peptic ulcer or gastro-intestinal reflux disease
Aspirin or nonsteroidal anti-inflammatory drug induced asthma
Allergy to paracetamol, parecoxib or sulphonamides
Hepatic dysfunction
Taking analgesic drugs within 24 hours of surgery
Unsuitable for anaesthesia with volatile anaesthetics or requiring intubation
Prophylactic antiemetic therapy indicated</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>Enrolment in preoperative clinic or ward after written informed consent
Allocation by sealed opaque envelope</concealment>
    <sequence>Computer generated</sequence>
    <masking>Blinded (masking used)</masking>
    <assignment>Factorial</assignment>
    <designfeatures>This study has a 2 x2 factorial design. This 2 x2 factorial design allows efficient evaluation of two treatments and in this case comparison not only of parecoxib versus placebo and paracetomol versus placebo but also the interaction of these two drugs (both versus placebo) and evaluation of all patients receiving each drug eg. Arms 1 &amp; 2 vs Arm 4 and Arms 2 &amp; 3 vs Arm 4</designfeatures>
    <endpoint>Efficacy</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Phase 4</phase>
    <anticipatedstartdate>1/05/2011</anticipatedstartdate>
    <actualstartdate>19/04/2011</actualstartdate>
    <anticipatedenddate />
    <actualenddate>14/08/2012</actualenddate>
    <samplesize>240</samplesize>
    <actualsamplesize>240</actualsamplesize>
    <recruitmentstatus>Completed</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate />
  </recruitment>
  <sponsorship>
    <primarysponsortype>Government body</primarysponsortype>
    <primarysponsorname>Women's and Newborn Health Service</primarysponsorname>
    <primarysponsoraddress>King Edward Memorial Hospital for Women
374 Bagot Rd
Subiaco WA 6008</primarysponsoraddress>
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Self funded/Unfunded</fundingtype>
      <fundingname />
      <fundingaddress />
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname />
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
    <othercollaborator>
      <othercollaboratortype>University</othercollaboratortype>
      <othercollaboratorname>The University of Western Australia</othercollaboratorname>
      <othercollaboratoraddress>35 Stirling Highway, Crawley WA 6009</othercollaboratoraddress>
      <othercollaboratorcountry>Australia</othercollaboratorcountry>
    </othercollaborator>
  </sponsorship>
  <ethicsAndSummary>
    <summary>The study objective is to compare the analgesic efficacy and quality of postoperative pain relief following minor gynaecological surgery between four different intra-operative analgesic regimens based on opioid plus either paracetamol, parecoxib, paracetamol and parecoxib in combination or placebo.
The null hypothesis is that there is no difference in the analgesic efficacy and quality of pain relief provided by either paracetamol, parecoxib, paracetamol and parecoxib in combination or placebo in patients undergoing minor gynaecological surgery.</summary>
    <trialwebsite>Nil</trialwebsite>
    <publication>Mohamad AH, McDonnell NJ, Bloor M, Nathan EA, Paech MJ. Parecoxib and paracetamol for pain relief following minor day-stay gynaecological surgery. Anaesth Intensive Care 2014;42(1):43-50</publication>
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Women's and Newborn Health Service Ethics Committee</ethicname>
      <ethicaddress>Administration
Princess Margaret Hospital
Roberts Rd
Subiaco WA 6008</ethicaddress>
      <ethicapprovaldate>18/03/2011</ethicapprovaldate>
      <hrec>1882/EW</hrec>
      <ethicsubmitdate />
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title>Prof</title>
      <name>Michael Paech</name>
      <address>Department of Anaesthesia and Pain Medicine
King Edward Memorial Hospital for Women
374 Bagot Rd, Subiaco WA 6008</address>
      <phone>61 8 9340 2250/00</phone>
      <fax>61 8 9340 2227</fax>
      <email>michael.paech@health.wa.gov.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title>Prof</title>
      <name>Michael Paech</name>
      <address>Department of Anaesthesia and Pain Medicine
King Edward Memorial Hospital for Women
374 Bagot Rd, Subiaco WA 6008</address>
      <phone>61 8 93402250/00</phone>
      <fax>61 8 9340 2227</fax>
      <email>michael.paech@health.wa.gov.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title>Prof</title>
      <name>Michael Paech</name>
      <address>Department of Anaesthesia and Pain Medicine
King Edward Memorial Hospital for Women
374 Bagot Rd, Subiaco WA 6008</address>
      <phone>61 8 9340 2250/00</phone>
      <fax>61 8 9340 2227</fax>
      <email>michael.paech@health.wa.gov.au</email>
      <country>Australia</country>
      <type>Updating Information</type>
    </contact>
    <contact>
      <title>A/Prof</title>
      <name>Nolan McDonnell</name>
      <address>Department of Anaesthesia and Pain Medicine
King Edward Memorial Hospital for Women
374 Bagot Rd
Subiaco
WA 6008</address>
      <phone>61 8 93402250</phone>
      <fax />
      <email>Nolan.McDonnell@health.wa.gov.au</email>
      <country>Australia</country>
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>